Quantum-Si to Participate at Two Upcoming Investor Conferences

November 1, 2023
PDF Version

BRANFORD, Conn.--(BUSINESS WIRE)--Nov. 1, 2023-- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced that it will be participating in two upcoming investor conferences:

  • Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
  • 6th Annual Evercore ISI HealthCONx Conference

About the Canaccord Genuity MedTech Diagnostics and Digital Health & Services Forum

Quantum-Si management will attend the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum, taking place at the Westin NY Grand Central on Thursday, November 16, 2023.

Jeff Hawkins, Chief Executive Officer of Quantum-Si, will participate in a fireside chat on Thursday, November 16, at 9:00 – 9:25 a.m. Eastern Time.

About the 6th Annual Evercore ISI HealthCONx Conference

Quantum-Si management will attend the 6th Annual Evercore ISI HealthCONx Conference, taking place at the Kimpton Epic Hotel in Miami, Florida on November 28-30, 2023.

Jeff Hawkins will participate in a fireside chat on Wednesday, November 29, at 7:55 – 8:15 a.m. Eastern Time.

Where to View

A live and archived webcast of both events will be available in the “Investors” section of the Quantum-Si website under Events & Presentations.

About Quantum-Si Incorporated
Quantum-Si, The Protein Sequencing Company™, is focused on revolutionizing the growing field of proteomics. The Company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable next-generation single-molecule protein sequencing and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing. Learn more at quantum-si.com.

Investors
Jeff Keyes
ir@quantum-si.com

Media
Katherine Atkinson
media@quantum-si.com

Source: Quantum-Si Incorporated